Life Sciences Tools and Services
Company Overview of Labcyte Inc.
Labcyte Inc., a biotechnology tools company, manufactures and delivers instruments that are used worldwide throughout the pharmaceutical industry, as well as by biotechnology companies, contract research organizations, and academic institutions. It offers Echo 525, a liquid handler that is designed primarily for biochemical and genomics reagent transfer; and Echo 550, a liquid handler for medium throughput screening and large genomics projects. The company also provides Access laboratory workstation, a ready-to-go robotic system for echo liquid handlers; POD automation platform for maximum throughput and capacity; Tempo, an automation control software that enables design and scheduling for c...
170 Rose Orchard Way
San Jose, CA 95134
Founded in 2000
Key Executives for Labcyte Inc.
Chief Executive Officer, President and Director
Founder, Chief Technology Officer and Director
Vice President of Finance
Managing Director of Europe Limited
Compensation as of Fiscal Year 2017.
Labcyte Inc. Key Developments
Labcyte Introduces New 384-Well Low Dead Volume Microplate for Echo® 525 Liquid Handlers
Sep 14 17
Labcyte Inc. announced the release of a new 384-well low dead volume microplate for its Echo® 525 Liquid Handlers. The new Echo® Qualified 384 LDV Plus Microplate reduces the amount of sample or reagent required in a well for transfer by 75% or more. Labcyte’s Echo 525 Liquid Handlers use focused sound energy to dispense precisely sized 25nL droplets of samples or reagents from microplate to microplate without the contact of tips or nozzles. Larger volume transfers are achieved by transferring several hundred droplets per second. This reduces costs by allowing miniaturization and leads to improved results by eliminating the contamination risks associated with tips. The speed at which Echo systems transfer fluid from any well on a microplate to any well on another microplate has driven its adoption for pooling in synthetic biology and genomics applications where DNA oligos, sequencing libraries and PCR primers are pooled in random combinations. With the ability to miniaturize reaction volumes while improving experimental outcomes, Echo system users in academic institutions as well as industrial biotechnology and pharmaceutical companies experience immediate improvements in efficiency and productivity.
Labcyte and SEngine Precision Medicine Collaborate to Offer Functional Drug Screening for Oncology
Aug 30 17
Labcyte Inc. and SEngine Precision Medicine announced the companies are collaborating to fulfill the promise of personalized medicine by employing Labcyte's advanced acoustic liquid handling solutions with SEngine's unique functional drug testing approach with the mission to match cancer patients to the most effective and least toxic therapies available. SEngine employs functional genomics and robotic testing of drugs in live patient organoids using the company's CLIA-certified P.A.R.I.S. assay. From a single sample taken from a patient's tumor, SEngine scientists can discover which drugs or combinations of drugs are most effective in killing or disabling that individual's cancer, and which therapies will most likely not work in a specific case - saving patients time, money, and unnecessary side effects. The test employs more than 100 drugs, carefully selected to include the and most up-to-date collection of targeted therapies, and is applicable to all major solid tumor types. Labcyte's Echo Liquid Handlers use the gentle energy of sound waves to transfer liquids with high accuracy and billionth of a liter precision. The ability to miniaturize and automate assays saves scientists time and money, and enables new types of assays that were previously inconceivable or too difficult with traditional methods. Acoustic liquid handling technology is contactless, eliminating the use of pipettes and reducing the volumes required for compounds and samples. SEngine is also using Labcyte's Access Laboratory Workstation to further automate its lab and increase throughput while preserving accuracy.
Labcyte Moves Global Headquarters to 60,000 Square Foot Building in San Jose
Jun 1 17
Labcyte Inc. relocated its global headquarters to San Jose, California, taking over a 60,000 square foot building at 170 Rose Orchard Way.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 23, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries